Wolf, Peter
Fellinger, Paul
Pfleger, Lorenz
Smajis, Sabina
Beiglböck, Hannes
Gajdošík, Martin
Anderwald, Christian-Heinz
Trattnig, Siegfried
Luger, Anton
Winhofer, Yvonne
Krššák, Martin
Krebs, Michael
Funding for this research was provided by:
Sanofi | Sanofi-Aventis Korea Company (unrestricted research grant)
Article History
Received: 26 September 2018
Accepted: 22 January 2019
First Online: 22 February 2019
Competing Interests
: M. Kre. has received research support from Sanofi and AstraZeneca as well as speaker and consulting fees from AstraZeneca, Novartis, Novo Nordisk, Lilly, Merck, Böhringer and Sanofi. A.L. received speaker and consulting fees from Lilly, Novo Nordisk and Sanofi. The other authors don’t have to report a potential conflict of interest. All other authors have nothing to declare.